Versant Venture Management as of March 31, 2020
Portfolio Holdings for Versant Venture Management
Versant Venture Management holds 9 positions in its portfolio as reported in the March 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Crispr Therapeutics (CRSP) | 48.6 | $177M | 4.2M | 42.14 | |
| Adverum Biotechnologies | 18.9 | $69M | 7.1M | 9.77 | |
| Akero Therapeutics (AKRO) | 15.9 | $58M | 2.7M | 21.20 | |
| Veracyte (VCYT) | 8.0 | $29M | 1.2M | 24.31 | |
| Gritstone Oncology Ord (GRTS) | 5.0 | $18M | 3.1M | 5.82 | |
| Ocular Therapeutix (OCUL) | 3.0 | $11M | 2.2M | 4.95 | |
| Cymabay Therapeutics | 0.2 | $805k | 544k | 1.48 | |
| Clovis Oncology | 0.2 | $648k | 102k | 6.36 | |
| Second Sight Med Prods | 0.1 | $559k | 562k | 0.99 |
